Literature DB >> 19871025

THE VASOCONSTRICTOR ACTION OF PLASMA FROM HYPERTENSIVE PATIENTS AND DOGS.

I H Page1.   

Abstract

1. Plasma from the renal vein, femoral artery or vein of normal dogs and plasma from the femoral artery, femoral and antecubital veins of man cause little or no vasoconstriction when added in small amounts to blood from a bilaterally nephrectomized dog used as perfusing medium in an isolated rabbit's ear. 2. Plasma from the femoral vessels and antecubital vein of patients with essential hypertension, malignant hypertension, and chronic nephritic hypertension causes marked vasoconstriction under the same circumstances. The plasma of dogs made hypertensive either by constriction of the parenchyma by the scar of silk perinephritis or by constriction of the renal artery by a clamp also causes pronounced vasoconstriction. 3. Plasma from the renal vein of normal dogs produces little or no vasoconstriction, but that of hypertensive dogs elicits vasoconstriction but usually not so marked as that elicited by plasma collected from peripheral vessels. A sample of renal venous plasma from one hypertensive patient caused severe vasoconstriction, not quite so intense as that produced by the peripheral vein plasma. 4. Since renin is liberated into the renal vein in large amounts in hypertensive dogs and reacts with renin-activator to produce angiotonin and since the conditions of the experiment are such as to enhance greatly the sensitivity of the ear preparation to angiotonin, it is believed that the vasoconstriction is the result of the presence of angiotonin in the peripheral blood. 5. Since vasoconstriction occurs under the same experimental conditions with plasma from both hypertensive patients and dogs, this is considered cogent evidence in favor of the view that the chemical mediator of both is similar and is possibly angiotonin. 6. A method is presented which is believed will distinguish between plasma from patients with normal blood pressure and that from those with hypertension, and between plasma from normal dogs and that from dogs with experimental renal hypertension.

Entities:  

Year:  1940        PMID: 19871025      PMCID: PMC2135062          DOI: 10.1084/jem.72.3.301

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  THE EFFECTS OF PRESSOR DRUGS AND OF SALINE KIDNEY EXTRACTS ON BLOOD PRESSURE AND SKIN TEMPERATURE.

Authors:  E M Landis; H Montgomery; D Sparkman
Journal:  J Clin Invest       Date:  1938-03       Impact factor: 14.808

2.  The blood-pressure raising secretion of the ischaemic kidney.

Authors:  J C Fasciolo; B A Houssay; A C Taquini
Journal:  J Physiol       Date:  1938-12-14       Impact factor: 5.182

3.  A METHOD FOR PRODUCING PERSISTENT HYPERTENSION BY CELLOPHANE.

Authors:  I H Page
Journal:  Science       Date:  1939-03-24       Impact factor: 47.728

4.  STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

Authors:  H Goldblatt; J Lynch; R F Hanzal; W W Summerville
Journal:  J Exp Med       Date:  1934-02-28       Impact factor: 14.307

5.  A CRYSTALLINE PRESSOR SUBSTANCE (ANGIOTONIN) RESULTING FROM THE REACTION BETWEEN RENIN AND RENIN-ACTIVATOR.

Authors:  I H Page; O M Helmer
Journal:  J Exp Med       Date:  1940-01-01       Impact factor: 14.307

6.  ON THE NATURE OF THE PRESSOR ACTION OF RENIN.

Authors:  I H Page
Journal:  J Exp Med       Date:  1939-10-31       Impact factor: 14.307

7.  ANGIOTONIN-ACTIVATOR, RENIN- AND ANGIOTONIN-INHIBITOR, AND THE MECHANISM OF ANGIOTONIN TACHYPHYLAXIS IN NORMAL, HYPERTENSIVE, AND NEPHRECTOMIZED ANIMALS.

Authors:  I H Page; O M Helmer
Journal:  J Exp Med       Date:  1940-03-31       Impact factor: 14.307

  7 in total
  5 in total

1.  [Renin and hypertension, physiological or pathological agents?].

Authors:  F GROSS
Journal:  Klin Wochenschr       Date:  1958-08-01

2.  [Effect of the liver on experimental renal hypertension due to intrarenal causes].

Authors:  L Brunner; B Heisig; H Emmermann
Journal:  Langenbecks Arch Chir       Date:  1970

3.  [Pathogenesis of renal hypertension (author's transl)].

Authors:  J Brod; J Bahlmann; M Cachovan; W Hubrich; H Hundeshagen
Journal:  Klin Wochenschr       Date:  1980-07-15

4.  THE METABOLISM OF THE ISCHEMIC KIDNEY : I. THE RESPIRATION AND THE OXIDASE ACTIVITY OF THE ISCHEMIC KIDNEY.

Authors:  S B Raska
Journal:  J Exp Med       Date:  1943-07-01       Impact factor: 14.307

5.  THE CARDIAC FACTOR IN THE "PRESSOR" EFFECTS OF RENIN AND ANGIOTONIN.

Authors:  W H Hill; E C Andrus
Journal:  J Exp Med       Date:  1941-06-30       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.